Australian Government - Department of Health

Medical Services Advisory Committee (MSAC)

1173 - Testing for epidermal growth factor receptor (EGFR) status in patients with locally advanced (stage IIIB) or metastatic (stage IV) non-small cell lung cancer (NSCLC) for access to erlotinib

The documents published on this page may not be accessible. If you need assistance please contact the MSAC Secretariat via email at msacweb@health.gov.au

Application Number1173
Application NameTesting for epidermal growth factor receptor (EGFR) status in patients with locally advanced (stage IIIB) or metastatic (stage IV) non-small cell lung cancer (NSCLC) for access to erlotinib
Description of Medical Service-
Description of Medical Condition-
ProtocolsPDF version Consultation Decision Analytic Protocol (PDF 372 KB)
Word version Consultation Decision Analytic Protocol (Word 932 KB)

PDF Version Final Decision Analytic Protocol (PDF 412 KB)
Word version Final Decision Analytic Protocol (Word 818 KB)
Consultation14 October 2011 - 4 November 2011
Reports-
MSAC OutcomesPDF version Public Summary Document - August 2012 (PDF 116 KB)
Word version Public Summary Document - August 2012 (Word 691 KB)

PDF version Public Summary Document - August 2013 (PDF 136 KB)
Word version Public Summary Document - August 2013 (Word 103 KB)

Meetings for this Application

Meeting TypeDate
PASC14 - 15 September 2011
1 - 2 December 2011
ESC -
MSAC 2 August 2012
1 August 2013

Page currency, Latest update: 07 November, 2014